MedTrace Logo

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

NCT04171661 · Status: ACTIVE_NOT_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2026-03-19

No results posted yet for this study

Summary

Single patient study. Patient diagnosed with dystrophic epidermolysis bullosa presenting chronic open wounds that are not responding to dressings, topical preparations (antimicrobials, antibiotics) and systemic agents (anti-inflammatory antibacterials). The Self-Assembled Skin Substitutes will be used to cover wounds.

Conditions

  • Epidermolysis Bullosa Dystrophica

Interventions

BIOLOGICAL

SASS

SASS applied on chronic skin wounds as skin graft

Sponsors & Collaborators

  • The Hospital for Sick Children

    collaborator OTHER

  • CHU de Quebec-Universite Laval

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-10
Primary Completion
2019-12-24
Completion
2026-12-18

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04171661 on ClinicalTrials.gov